左心衰中的右心-肺循环单元受累:诊断、预后与治疗意义
本文综述左心衰(射血分数降低或保留)中右心-肺循环单元的受累机制与临床意义。肺微循环慢性负荷导致右室肥厚、右房扩张及舒张功能障碍,进展为右室扩张和收缩功能障碍时出现右室-肺动脉耦联失败。临床应综合临床评估、生物标志物和影像学评估右心,但尚无单一参数可独立预测预后,且缺乏循证管理策略。
要点
- 左心衰患者应评估右心-肺循环单元,包括右室收缩功能、肺动脉压力、右室-肺动脉耦联及右心形态。
- 右心功能障碍与心衰进展相关,但无单一参数可独立预测预后。
- 针对右心功能障碍的循证治疗策略尚缺乏,是当前未满足的临床需求。
核心结论
- 右心是左心衰(射血分数降低或保留)进展中的关键参与者,但针对右心功能障碍的循证管理策略仍缺乏。
研究设计与样本
- 综述,未报告系统检索范围与样本量。
主要发现
- 肺微循环慢性负荷早期表现为右室肥厚、右房扩张和舒张功能障碍。
- 进展为右室扩张和收缩功能障碍时,出现右室-肺动脉耦联失败伴右室输出量降低,即右心衰竭。
- 无单一参数可独立预测心衰预后,需同时评估右室收缩功能、肺动脉压力、右室-肺动脉耦联及右心形态。
临床怎么用
- 对左心衰患者,应结合临床评估、生物标志物和影像学综合评估右心-肺循环单元。
- 评估内容应同时涵盖右室收缩功能、肺动脉压力、右室-肺动脉耦联估计及右心形态特征。
局限性
- 尽管有大量证据表明右心功能与心衰临床综合征相关,但缺乏循证管理策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although long neglected, the right side of the heart (RH) is now widely accepted as a pivotal player in heart failure (HF) either with reduced or preserved ejection fraction. The chronic overload of the pulmonary microcirculation results in an initial phase characterized by right ventricular (RV) hypertrophy, right atrial dilation, and diastolic dysfunction. This progresses to overt RH failure when RV dilation and systolic dysfunction lead to RV-pulmonary arterial (RV-PA) uncoupling with low RV output. In the context of its established relevance to progression of HF, clinicians should consider assessment of the RH with information from clinical assessment, biomarkers, and imaging. Notably, no single parameter can predict prognosis alone in HF. Assessments simultaneously should encompass RV systolic function, pulmonary pressures, an estimation of RV-PA coupling, and RH morphologic features. Despite a large volume of evidence indicating the relevance of RH function to the clinical syndrome of HF, evidence-based management strategies are lacking. Targeting RH dysfunction in HF should be an objective of future investigations, being an unmet need in the current management of HF.
引用
- Marra AM, Sherman AE, Salzano A, et al. Right Side of the Heart Pulmonary Circulation Unit Involvement in Left-Sided Heart Failure: Diagnostic, Prognostic, and Therapeutic Implications. Chest. 2021. PMID: 34592320. doi:10.1016/j.chest.2021.09.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。